• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死的年轻患者(<45岁)的特征及预后分析

Characterization of features and outcomes of young patients (< 45 years) presenting with ST-segment elevation myocardial infarction.

作者信息

Samir Ahmad, Almahjori Mohammed, Zarif Basem, Elshinawi Mai, Yehia Hesham, Elhafy Mohamed, Shehata Ahmed, Farrag Azza

机构信息

Faculty of Medicine, Cairo University, Cairo, Egypt.

National Heart Institute, Cairo, Egypt.

出版信息

Egypt Heart J. 2023 Apr 25;75(1):32. doi: 10.1186/s43044-023-00357-2.

DOI:10.1186/s43044-023-00357-2
PMID:37097520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10127970/
Abstract

BACKGROUND

Coronary artery disease (CAD) is the commonest cause of death worldwide. ST-segment elevation myocardial infarction (STEMI) and its consequences can be devastating particularly at younger age for a bigger impact on the patient's psychology and ability to work. Little is known about the differential features and outcomes of young STEMI patients in Egypt. This study characterized young STEMI patients (≤ 45 years) compared to patients > 45 years and evaluated 1-year outcomes.

RESULTS

A total of 492 eligible STEMI patients who presented to the National Heart Institute and Cairo University Hospitals were recruited. Young STEMI patients (< 45 years old) represented 20% of all STEMI comers. Male gender was predominant in both groups, yet with a significantly higher proportion in the younger compared to older patients (87% vs. 73%, p = 0.004). Compared to older patients, young STEMI patients had characteristically higher rates of smoking (72.4% vs. 49.7%, p < 0.001) and family history (13.3% vs. 4.8%, p = 0.002), while significantly lower rate of other conventional CAD risk factors as diabetes, hypertension, and dyslipidemia (20.4% vs. 44.7%, 20.4% vs. 44.9% and 12.7% vs. 21.8%, respectively, p < 0.05 for all). Follow-up was continued for at least 12 months after the index event. Younger STEMI patients had fewer major adverse cardiovascular events and fewer heart failure hospitalizations compared to the older controls (10.2 vs. 23.9% and 18.4% vs. 34.8%, respectively, p < 0.005 for both), however, 1-year mortality was similar (3.1% vs. 4.1%, p = 0.64).

CONCLUSIONS

Younger STEMI patients (≤ 45 years) show peculiar characteristics, with significantly higher rates of smoking and family history of premature CAD, while less prevalence of other conventional CAD risk factors. Overall MACE occurred less in younger STEMI patients; however, the mortality rate was similar to the older controls.

摘要

背景

冠状动脉疾病(CAD)是全球最常见的死亡原因。ST段抬高型心肌梗死(STEMI)及其后果可能是毁灭性的,尤其是在较年轻的患者中,对其心理和工作能力会产生更大影响。关于埃及年轻STEMI患者的差异特征和预后知之甚少。本研究对年轻STEMI患者(≤45岁)与年龄大于45岁的患者进行了特征描述,并评估了1年的预后情况。

结果

共招募了492例符合条件的STEMI患者,这些患者均在国家心脏研究所和开罗大学医院就诊。年轻STEMI患者(<45岁)占所有STEMI患者的20%。两组中男性均占主导,但年轻患者中的比例显著高于老年患者(87%对73%,p = 0.004)。与老年患者相比,年轻STEMI患者的吸烟率(72.4%对49.7%,p < 0.001)和家族病史(13.3%对4.8%,p = 0.002)特征性地更高,而其他传统CAD危险因素如糖尿病、高血压和血脂异常的发生率则显著更低(分别为20.4%对44.7%、20.4%对44.9%和12.7%对21.8%,所有p < 0.05)。在索引事件后持续随访至少12个月。与老年对照组相比,年轻STEMI患者的主要不良心血管事件和心力衰竭住院次数更少(分别为10.2%对23.9%和18.4%对34.8%,两者p < 0.005),然而,1年死亡率相似(3.1%对4.1%,p = 0.64)。

结论

年轻STEMI患者(≤45岁)表现出特殊特征,吸烟率和CAD早发家族史显著更高,而其他传统CAD危险因素的患病率更低。总体而言,年轻STEMI患者发生主要不良心血管事件较少;然而,死亡率与老年对照组相似。

相似文献

1
Characterization of features and outcomes of young patients (< 45 years) presenting with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死的年轻患者(<45岁)的特征及预后分析
Egypt Heart J. 2023 Apr 25;75(1):32. doi: 10.1186/s43044-023-00357-2.
2
Acute ST-Elevation Myocardial Infarction in the Young Compared With Older Patients in the Tamil Nadu STEMI Program.泰米尔纳德邦 STEMI 项目中青年与老年急性 ST 段抬高型心肌梗死患者的比较。
Heart Lung Circ. 2021 Dec;30(12):1876-1882. doi: 10.1016/j.hlc.2021.04.013. Epub 2021 Jun 1.
3
Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗的年轻患者的非典型危险因素特征及出色的长期预后
Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):23-32. doi: 10.1177/2048872614567453. Epub 2015 Jan 14.
4
Clinical Characteristics and Outcomes of ST-Elevation Myocardial Infarction in Young Patients: A Single-Center Experience.年轻患者ST段抬高型心肌梗死的临床特征与预后:一项单中心经验
Cureus. 2024 Feb 6;16(2):e53688. doi: 10.7759/cureus.53688. eCollection 2024 Feb.
5
Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.短暂性ST段抬高与持续性ST段抬高及非ST段抬高型心肌梗死的特征、管理与结局
Am J Cardiol. 2018 Jun 15;121(12):1449-1455. doi: 10.1016/j.amjcard.2018.02.029. Epub 2018 Mar 12.
6
The Impact of Smoking Status 1 Year After ST-Segment Elevation Myocardial Infarction on Cardiovascular Events and Mortality in Patients Aged ≤60 Years.ST 段抬高型心肌梗死 1 年后的吸烟状况对≤60 岁患者心血管事件和死亡率的影响。
Am J Cardiol. 2022 Jul 15;175:52-57. doi: 10.1016/j.amjcard.2022.04.019. Epub 2022 May 22.
7
Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.早发冠心病家族史对接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗患者临床结局的临床特征及影响:来自HORIZONS-AMI试验的分析
Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):375-80. doi: 10.1016/j.carrev.2014.09.002. Epub 2014 Sep 16.
8
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).无明显冠状动脉疾病的 ST 段抬高型心肌梗死患者的长期预后(来自 HORIZONS-AMI 试验)。
Am J Cardiol. 2013 Mar 1;111(5):643-8. doi: 10.1016/j.amjcard.2012.11.011. Epub 2012 Dec 19.
9
One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.直接经皮冠状动脉介入治疗无保护左主干冠状动脉闭塞所致 ST 段抬高型心肌梗死患者 1 年的转归。
Chin Med J (Engl). 2018 Jun 20;131(12):1412-1419. doi: 10.4103/0366-6999.233948.
10
Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.性别对中青年 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗短期和长期结局的影响。
Chin Med J (Engl). 2018 Jun 20;131(12):1420-1429. doi: 10.4103/0366-6999.233965.

引用本文的文献

1
Surgical versus percutaneous closure of post-infarction ventricular septal rupture; review of literature and single-center experience.心肌梗死后室间隔破裂的外科手术与经皮封堵治疗:文献综述及单中心经验
BMC Cardiovasc Disord. 2025 Mar 12;25(1):174. doi: 10.1186/s12872-024-04370-4.
2
Clinical, electrocardiographic, echocardiographic, and angiographic predictors for the final infarct size assessed by cardiac magnetic resonance in acute STEMI patients after primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者中,通过心脏磁共振评估最终梗死面积的临床、心电图、超声心动图和血管造影预测因素。
Egypt Heart J. 2024 Aug 24;76(1):111. doi: 10.1186/s43044-024-00526-x.
3
Clinical Characteristics and Outcomes of ST-Elevation Myocardial Infarction in Young Patients: A Single-Center Experience.年轻患者ST段抬高型心肌梗死的临床特征与预后:一项单中心经验
Cureus. 2024 Feb 6;16(2):e53688. doi: 10.7759/cureus.53688. eCollection 2024 Feb.
4
Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors.年轻的、首发且未接受过药物治疗的重度抑郁症患者的甲状腺功能障碍:患病率及相关临床因素
Front Psychiatry. 2023 Jun 30;14:1156481. doi: 10.3389/fpsyt.2023.1156481. eCollection 2023.
5
Predictive value of CHADSVASC score for contrast-induced nephropathy after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction.CHADSVASC评分对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后对比剂肾病的预测价值。
Egypt Heart J. 2023 Jun 26;75(1):52. doi: 10.1186/s43044-023-00378-x.

本文引用的文献

1
Coronary Artery Disease in Very Young Patients: Analysis of Risk Factors and Long-Term Follow-Up.极年轻患者的冠状动脉疾病:危险因素分析及长期随访
J Cardiovasc Dev Dis. 2022 Mar 11;9(3):82. doi: 10.3390/jcdd9030082.
2
Clinical Characteristics and Prognosis of Young Middle Eastern Adults with ST-Elevation Myocardial Infarction: One-Year Follow-Up.中东地区年轻成人ST段抬高型心肌梗死的临床特征与预后:一年随访
Heart Views. 2021 Apr-Jun;22(2):88-95. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_67_20. Epub 2021 Aug 19.
3
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
4
Acute ST-Elevation Myocardial Infarction in the Young Compared With Older Patients in the Tamil Nadu STEMI Program.泰米尔纳德邦 STEMI 项目中青年与老年急性 ST 段抬高型心肌梗死患者的比较。
Heart Lung Circ. 2021 Dec;30(12):1876-1882. doi: 10.1016/j.hlc.2021.04.013. Epub 2021 Jun 1.
5
Characteristics and outcomes of young patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: retrospective analysis in a multiethnic Asian population.在多民族亚洲人群中进行的经皮冠状动脉介入治疗的年轻 ST 段抬高型心肌梗死患者的特征和结局:回顾性分析。
Open Heart. 2021 Jan;8(1). doi: 10.1136/openhrt-2020-001437.
6
Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex-Related Differences, 2000 to 2016.早发动脉粥样硬化性心血管疾病:2000 年至 2016 年的发病率、危险因素和性别差异趋势。
J Am Heart Assoc. 2019 Jul 16;8(14):e012178. doi: 10.1161/JAHA.119.012178. Epub 2019 Jul 8.
7
Cardiogenic Shock.心源性休克
J Am Heart Assoc. 2019 Apr 16;8(8):e011991. doi: 10.1161/JAHA.119.011991.
8
Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.急性肾损伤与收缩压干预试验中心血管事件和死亡的关系。
Am J Nephrol. 2019;49(5):359-367. doi: 10.1159/000499574. Epub 2019 Apr 2.
9
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
Circulation. 2018 Nov 13;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617.
10
Coronary Heart Disease in the Middle East and North Africa: Current Status and Future Goals.中东和北非地区的冠心病:现状与未来目标
Curr Atheroscler Rep. 2017 May;19(5):24. doi: 10.1007/s11883-017-0659-9.